TDP‐43 pathology and functional deficits in wild‐type and ALS/FTD mutant cyclin F mouse models
Neuropathology and Applied Neurobiology · 2023
DOI: 10.1111/nan.12902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2023. Verfasst von Annika van Hummel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Au…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Frontotemporal Dementia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council, Motor Neurone Disease Research Australia.
Abstract (Originalsprache)
Aims
Amyotrophic lateral sclerosis (ALS) is characterised by a progressive loss of upper and lower motor neurons leading to muscle weakness and eventually death. Frontotemporal dementia (FTD) presents clinically with significant behavioural decline. Approximately 10% of cases have a known family history, and disease‐linked mutations in multiple genes have been identified in FTD and ALS. More recently, ALS and FTD‐linked variants have been identified in the CCNF gene, which accounts for an estimated 0.6% to over 3% of familial ALS cases.
Methods
In this study, we developed the first mouse models expressing either wild‐type (WT) human CCNF or its mutant pathogenic variant S621G to recapitulate key clinical and neuropathological features of ALS and FTD linked to CCNF disease variants. We expressed human CCNF WT or CCNF S621G throughout the murine brain by intracranial delivery of adeno‐associated virus (AAV) to achieve widespread delivery via somatic brain transgenesis.
Results
These mice developed behavioural abnormalities, similar to the clinical symptoms of FTD patients, as early as 3 months of age, including hyperactivity and disinhibition, which progressively deteriorated to include memory deficits by 8 months of age. Brains of mutant CCNF_S621G mice displayed an accumulation of ubiquitinated proteins with elevated levels of phosphorylated TDP‐43 present in both CCNF_WT and mutant CCNF_S621G mice. We also investigated the effects of CCNF expression on interaction targets of CCNF and found elevated levels of insoluble splicing factor proline and glutamine‐rich (SFPQ). Furthermore, cytoplasmic TDP‐43 inclusions were found in both CCNF_WT and mutant CCNF_S621G mice, recapitulating the key hallmark of FTD/ALS pathology.
Conclusions
In summary, CCNF expression in mice reproduces clinical presentations of ALS, including functional deficits and TDP‐43 neuropathology with altered CCNF‐mediated pathways contributing to the pathology observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
- Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, 81377, Germany.
- Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
ORCID-Profile: Yazi D Ke
Förderung
- Australian Research Council
- National Health and Medical Research Council
- Motor Neurone Disease Research Australia
- Macquarie University
Zitieren
APA
van Hummel, A., Sabale, M., Przybyla, M., van der Hoven, J., Chan, G., Feiten, A. F., Chung, R. S., Ittner, L. M., & Ke, Y. D. (2023). TDP‐43 pathology and functional deficits in wild‐type and ALS/FTD mutant cyclin F mouse models. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12902
Vancouver
van Hummel A, Sabale M, Przybyla M, van der Hoven J, Chan G, Feiten AF, et al. TDP‐43 pathology and functional deficits in wild‐type and ALS/FTD mutant cyclin F mouse models. Neuropathology and Applied Neurobiology. 2023. doi:10.1111/nan.12902
BibTeX
@article{vanHummel2023,
author = {van Hummel, Annika and Sabale, Miheer and Przybyla, Magdalena and van der Hoven, Julia and Chan, Gabriella and Feiten, Astrid F and Chung, Roger S and Ittner, Lars M and Ke, Yazi D},
title = {TDP‐43 pathology and functional deficits in wild‐type and ALS/FTD mutant cyclin F mouse models},
journal = {Neuropathology and Applied Neurobiology},
year = {2023},
doi = {10.1111/nan.12902}
}
EUVIMED